SRx Health Solutions Shareholders Unanimously Approve Acquisition by Better Choice Company
TAMPA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that SRx…
Faircourt Asset Management Inc. Announces February Distribution
Toronto, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of…
Sysco Halts All Purchases from Fort Wayne, Ind. Facility that Supplied Frozen Shakes Linked to Listeria Outbreak and Recalls Related Products
HOUSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Today, Sysco Corporation, the leading global foodservice distribution company, recalled frozen supplemental shakes linked to a Listeria monocytogenes outbreak and halted all purchases…
Press Release Related to a Proposed Public Buy-Out Offer Followed by a Squeeze-Out Concerning Tarkett’s Shares
This press release does not constitute an offer to purchase securities. The offer described hereafter can only be opened once it has been declared compliant by the Financial Markets Authority.…
COMMUNIQUE RELATIF AU DEPOT D’UN PROJET D’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIETE TARKETT
Ce communiqué ne constitue pas une offre d’acquérir des titres. L’offre décrite ci-après ne pourra être ouverte qu’une fois déclarée conforme par l’Autorité des Marchés Financiers. COMMUNIQUE RELATIF AU DEPOT…
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different dosesNew endpoints presented include findings on clinical and…
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in…
First AGIC event in India set for April 9
First AGIC event in India set for April 9 | World Grain Skip To Content Please visit: Our Sponsor
Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn
ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de…
Excitement Builds at CPAC 2025 as President Donald J. Trump to Take Center Stage — FRANKSPEECH NETWORK, INC further known as Mike Lindell Media Corp. (OTC Pink “FSBN”) as Mike Lindell and His Lovely Team take on the Final Day at CPAC 2025.
Washington, D.C., Feb. 22, 2025 (GLOBE NEWSWIRE) -- BREAKING NEWS: FrankSpeech Network, Inc (“FSBN”), currently being rebranded as Mike Lindell Media Corp., today announced their final day at CPAC 2025…